Related Experiment Video
Updated: Aug 20, 2025

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Neurodevelopment in infants with antenatal or early neonatal exposure to SARS-CoV-2
Sarah B Mulkey1, Meagan E Williams2, Nadia Jadeed2
1Children's National Hospital, 111 Michigan Ave NW, Washington, DC 20010, United States; Department of Neurology, The George Washington University School of Medicine and Health Sciences, 2300 I St NW, Washington, DC 20037, United States; Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, 2300 I St NW, Washington, DC 20037, United States.
Insights
Infants exposed to SARS-CoV-2 in utero, particularly from symptomatic mothers, showed more frequent neurodevelopmental delays. Early screening is crucial for these infants to monitor and address potential delays.
Area of Science:
- Pediatric Neurology
- Developmental Pediatrics
- Infectious Diseases
Background:
- Prenatal and neonatal viral infections pose risks to infant brain development.
- A specialized program at Children's National Hospital tracks infants with SARS-CoV-2 exposure.
Purpose of the Study:
- To assess the neurodevelopmental impact of early SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) exposure in infants.
- To identify specific risks associated with different exposure types (in utero vs. neonatal).
Main Methods:
- Prospective observational study of 34 infants evaluated between March 2020 and November 2021.
- Data collected included demographics, maternal health, SARS-CoV-2 status, and neonatal intensive care unit (NICU) records.
- Infants underwent neurologic examinations and developmental screening using the Ages and Stages Questionnaire (ASQ).
Main Results:
- Most infants (82%) had in utero exposure, with 16 from symptomatic mothers (IU-S) and 12 from asymptomatic mothers (IU-A).
- IU-S infants exhibited more frequent abnormal neurologic exams and ASQ scores below cut-offs compared to IU-A and neonatally exposed infants.
- Significant differences were observed in Fine Motor (P=.01) and Personal-Social (P=.02) domains for IU-S infants compared to IU-A.
Conclusions:
- Early SARS-CoV-2 exposure, especially in utero to symptomatic mothers, may negatively affect infant neurodevelopment.
- Preventing early-life infections through vaccination and precautions is vital for protecting against neurodevelopmental delays.
- Infants with early SARS-CoV-2 exposure require ongoing neurodevelopmental screening and monitoring.
Background:
Antenatal and neonatal viral exposure may put the developing brain at risk for abnormal neurodevelopment. A clinical program at Children's National Hospital provides detailed follow-up of infants with in utero or neonatal SARS-CoV-2 exposure.
Aims:
To determine impact of early SARS-CoV-2 exposure on neurodevelopment.
Study Design:
We performed a prospective observational study of infant evaluations between 3/2020 and 11/2021. Demographics, pregnancy and birth details, SARS-CoV-2 data, specialty consultations, and NICU records were extracted from infants' medical records. Infants had neurologic exams and developmental screening with Ages and Stages Questionnaire (ASQ). Correlations between SARS-CoV-2 exposure type and neurodevelopmental outcomes were analyzed.
Subjects:
Thirty-four infants evaluated in the SARS-CoV-2 follow-up program.
Outcome Measures:
Abnormal neurologic exams or ASQ scores near or below suggested cut-offs.
Results:
Infants received up to three evaluations. Most (28/34; 82 %) were exposed in utero - 16 to symptomatic mothers (IU-S) and 12 to asymptomatic mothers (IU-A). Six were exposed only as a neonate. IU-S had abnormal neurologic exams at mean (SD) age 112 (24) days and ASQ scores near or below cut-offs for all domains more frequently than IU-A or neonatally exposed infants. IU-S were more likely to score below any ASQ cutoff compared to IU-A (P = .04); differences were significant for Fine Motor (P = .01) and Personal-Social (P = .02) domains.
Conclusions:
Early SARS-CoV-2 exposure may impact neurodevelopment, especially among infants exposed in utero to symptomatic gestational parents. Vaccination and other precautions to reduce early-in-life infection may protect against neurodevelopmental delays. Children with early SARS-CoV-2 exposure should have additional longitudinal screening for neurodevelopmental delays.
More Related Videos
Related Concept Videos
Teratogenicity
Neurulation
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Socioemotional Development during Infancy
Primary Temperament Types

